Literature DB >> 3281898

Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of growth in mucus.

E A Wadolkowski1, D C Laux, P S Cohen.   

Abstract

The relative colonizing abilities of Escherichia coli F-18, isolated from the feces of a healthy human, and E. coli F-18col-, a strain derived from it which does not make the E. coli F-18 colicin, were studied. In a previous report, it was shown that when each strain was fed individually to streptomycin-treated mice, at approximately 10(10) CFU per mouse, each colonized the large intestine at between 10(7) and 10(8) CFU/g of feces indefinitely. However, when simultaneously fed to mice, although E. coli F-18 colonized at about 10(8) CFU/g of feces, E. coli F-18col- dropped to a level of 10(3) CFU/g of feces within 3 to 5 days. In the present investigation, we show that when given enough time to establish a state of colonization, E. coli F-18col- persists in feces in high numbers despite subsequent challenge by E. coli F-18. Therefore, a major defect in the ability of E. coli F-18col- to colonize in the presence of E. coli F-18 appears to be in initiating that state. In addition, when mucus was scraped from the cecal wall and, without further treatment, was inoculated with E. coli F-18 or F-18col-, both strains grew well. However, when cecal mucus was inoculated with both strains simultaneously, E. coli F-18 grew far more rapidly than E. coli F-18col-. Moreover, neither strain grew in cecal luminal contents. Together, these data suggest the possibility that both E. coli F-18 and F-18col- must grow in mucus to colonize the streptomycin-treated mouse large intestine, that E. coli F-18col- is eliminated by E. coli F-18 because it does not grow in mucus as well as E. coli F-18, and that E. coli F-18col- can resist elimination by E. coli F-18 if it is allowed enough time to establish itself within the mucus layer.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3281898      PMCID: PMC259757          DOI: 10.1128/iai.56.5.1030-1035.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Antibacterial mechanisms of the mouse gut. II. The role of Eh and volatile fatty acids in the normal gut.

Authors:  G G MEYNELL
Journal:  Br J Exp Pathol       Date:  1963-04

2.  Cholesterol lowering, fecal bile acid, and sterol changes during neomycin and colchicine.

Authors:  A Rubulis; M Rubert; W W Faloon
Journal:  Am J Clin Nutr       Date:  1970-09       Impact factor: 7.045

3.  Intestinal glycoproteins of germfree rats. Chemical composition of intestinal and fecal mucus from germfree rats fed a chemically defined diet.

Authors:  J K Wold; R Khan; T Midtvedt
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

4.  Adhesion of commensal bacteria to the large intestine wall in humans.

Authors:  C L Hartley; C S Neumann; M H Richmond
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

5.  Lipid composition of the gastric mucous barrier in the rat.

Authors:  A Slomiany; S Yano; B L Slomiany; G B Glass
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

6.  Survival and implantation of Escherichia coli in the intestinal tract.

Authors:  R Freter; H Brickner; J Fekete; M M Vickerman; K E Carey
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

7.  Continuous-flow cultures as in vitro models of the ecology of large intestinal flora.

Authors:  R Freter; E Stauffer; D Cleven; L V Holdeman; W E Moore
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

8.  Altered colonizing ability for mouse large intestine of a surface mutant of a human faecal isolate of Escherichia coli.

Authors:  M L Myhal; P S Cohen; D C Laux
Journal:  J Gen Microbiol       Date:  1983-05

9.  Relative colonizing abilities of human fecal and K 12 strains of Escherichia coli in the large intestines of streptomycin-treated mice.

Authors:  M L Myhal; D C Laux; P S Cohen
Journal:  Eur J Clin Microbiol       Date:  1982-06       Impact factor: 3.267

10.  RESISTANCE OF THE MOUSE'S INTESTINAL TRACT TO EXPERIMENTAL SALMONELLA INFECTION. II. FACTORS RESPONSIBLE FOR ITS LOSS FOLLOWING STREPTOMYCIN TREATMENT.

Authors:  M BOHNHOFF; C P MILLER; W R MARTIN
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

View more
  64 in total

1.  Estimation of growth rates of Escherichia coli BJ4 in streptomycin-treated and previously germfree mice by in situ rRNA hybridization.

Authors:  C U Rang; T R Licht; T Midtvedt; P L Conway; L Chao; K A Krogfelt; P S Cohen; S Molin
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

Review 2.  The acetate switch.

Authors:  Alan J Wolfe
Journal:  Microbiol Mol Biol Rev       Date:  2005-03       Impact factor: 11.056

3.  Use of norfloxacin to study colonization ability of Escherichia coli in in vivo and in vitro models of the porcine gut.

Authors:  E M Nielsen; J Schlundt
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

4.  Influence of the RpoS (KatF) sigma factor on maintenance of viability and culturability of Escherichia coli and Salmonella typhimurium in seawater.

Authors:  P M Munro; G N Flatau; R L Clément; M J Gauthier
Journal:  Appl Environ Microbiol       Date:  1995-05       Impact factor: 4.792

5.  Growth of Escherichia coli K88 in piglet ileal mucus: protein expression as an indicator of type of metabolism.

Authors:  L Blomberg; L Gustafsson; P S Cohen; P L Conway; A Blomberg
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

6.  Physiological state of Escherichia coli BJ4 growing in the large intestines of streptomycin-treated mice.

Authors:  L K Poulsen; T R Licht; C Rang; K A Krogfelt; S Molin
Journal:  J Bacteriol       Date:  1995-10       Impact factor: 3.490

7.  Role of Escherichia coli P fimbriae in intestinal colonization in gnotobiotic rats.

Authors:  M V Herías; T Midtvedt; L A Hanson; A E Wold
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  Genes of the GadX-GadW regulon in Escherichia coli.

Authors:  Don L Tucker; Nancy Tucker; Zhuo Ma; John W Foster; Regina L Miranda; Paul S Cohen; Tyrrell Conway
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

9.  Growth of Vibrio anguillarum in Salmon Intestinal Mucus.

Authors:  T Garcia; K Otto; S Kjelleberg; D R Nelson
Journal:  Appl Environ Microbiol       Date:  1997-03       Impact factor: 4.792

10.  The importance of P and type 1 fimbriae for the persistence of Escherichia coli in the human gut.

Authors:  K Tullus; I Kühn; I Orskov; F Orskov; R Möllby
Journal:  Epidemiol Infect       Date:  1992-06       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.